pyrroles has been researched along with Prediabetes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, SN | 1 |
| Bhagat, A; Bhosle, D; Bhosle, V; Bobde, J; Kadam, R; Shaikh, H | 1 |
| Bachowski, R; Gdula-Dymek, A; Krysiak, R; Okopien, B | 1 |
| Economides, PA; Horton, ES; Mantzoros, CS; Shetty, GK; Veves, A | 1 |
| Kaupper, T; Walter, M; Ziegler, AG | 1 |
1 review(s) available for pyrroles and Prediabetes
| Article | Year |
|---|---|
[Immunointervention in newly diagnosed type 1 diabetes].
Topics: Antibodies, Monoclonal; Atorvastatin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Heptanoic Acids; Humans; Immunosuppressive Agents; Insulin-Secreting Cells; Prediabetic State; Pyrroles | 2006 |
3 trial(s) available for pyrroles and Prediabetes
| Article | Year |
|---|---|
Study of Saroglitazar in Treatment Of Pre-diabetes with Dyslipidemia: STOP-D.
Topics: Dyslipidemias; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Phenylpropionates; Prediabetic State; Prospective Studies; Pyrroles; Triglycerides | 2018 |
Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.
Topics: Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Cytokines; Factor VII; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Prediabetic State; Pyrroles | 2010 |
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
Topics: Adiponectin; Adult; Age Distribution; Aged; Atorvastatin; Biomarkers; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Heptanoic Acids; Hormones, Ectopic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Prediabetic State; Predictive Value of Tests; Probability; Prognosis; Pyrroles; Reference Values; Resistin; Risk Assessment; Sex Distribution; Vascular Resistance | 2004 |
1 other study(ies) available for pyrroles and Prediabetes
| Article | Year |
|---|---|
The Road to Preventing Diabetes: Addressing Prediabetes and Concomitant Dyslipidemia.
Topics: Diabetes Mellitus; Dyslipidemias; Humans; Phenylpropionates; Prediabetic State; Pyrroles | 2018 |